Search the site

Theme Leads

Read about the Research Focus Area Leads at the Children's Diabetes Centre.

News & Events

Self-efficacy groups 2020

Perth Children’s Hospital’s Diabetes Service has released the dates for its self-efficacy groups for 2020.

News & Events

Rockingham stalwart retires

After more than 25 years in the diabetes space, clinical nurse and credentialled diabetes educator Maxine Schlaeppi has retired.v

News & Events

Technology proves a gamechanger

Heidi Bucktin likes to think of her family’s life as pre and post continuous glucose monitoring – that’s how markedly different the two periods are in their journey of living with a child with type 1 diabetes.

News & Events

Georgia wants to be part of the solution

Georgia Egan, 16,recently completed a six-month Hybrid Closed-Loop Outpatient Trial, the longest and largest at-home trial of a hybrid closed-loop insulin pump.

News & Events

ATAR special provisions still open for newly diagnosed

The deadline for ATAR exam special provisions is still open for newly diagnosed Type 1 Diabetes patients.

News & Events

Diabete$ Re$earch in Au$tralia

It may surprise you to know that the Australian government has invested almost $300 million dollars since 2000 towards research and clinical trials for diabetes

Rio Tinto Children’s Diabetes Centre Scholarships

Honours/Masters scholarship - now open Applications are open for our Honours / Masters Scholarships with the purpose of providing funding for

Research

Six months of hybrid closed-loop therapy improves diabetes-specific positive well-being, and reduces diabetes distress and fear of hypoglycemia: secondary analysis of a controlled trial

This analysis aimed to investigate diabetes-specific psychological outcomes among adults with type 1 diabetes (T1D) using hybrid closed-loop (HCL) versus standard therapy.

Research

Advances in Automated Insulin Delivery with the Medtronic 780G: The Australian Experience

To assess the real-world performance of MiniMed™ 780G for Australians with type 1 diabetes (T1D) following advanced hybrid closed loop (AHCL) activation and to evaluate the effect of changing from MiniMed 670/770G to 780G.